GEVO Strangle Strategy
GEVO (Gevo, Inc.), in the Basic Materials sector, (Chemicals - Specialty industry), listed on NASDAQ.
Gevo, Inc. operates as a renewable fuels company. It operates through four segments: Gevo, Agri-Energy, Renewable Natural Gas, and Net-Zero. The company commercializes gasoline, jet fuel, and diesel fuel to achieve zero carbon emissions, and reduce greenhouse gas emissions with sustainable alternatives. Its products also include renewable gasoline and diesel, isooctane, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein. Gevo, Inc. has a strategic alliance with Axens North America, Inc. for ethanol-to-jet technology and sustainable aviation fuel commercial project development. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006.
GEVO (Gevo, Inc.) trades in the Basic Materials sector, specifically Chemicals - Specialty, with a market capitalization of approximately $421.1M, a beta of 1.01 versus the broader market, a 52-week range of 1.07-2.97, average daily share volume of 4.2M, a public-listing history dating back to 2011, approximately 122 full-time employees. These structural characteristics shape how GEVO stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.01 places GEVO roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a strangle on GEVO?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current GEVO snapshot
As of May 15, 2026, spot at $1.67, ATM IV 96.60%, IV rank 24.68%, expected move 27.69%. The strangle on GEVO below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on GEVO specifically: GEVO IV at 96.60% is on the cheap side of its 1-year range, which favors premium-buying structures like a GEVO strangle, with a market-implied 1-standard-deviation move of approximately 27.69% (roughly $0.46 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated GEVO expiries trade a higher absolute premium for lower per-day decay. Position sizing on GEVO should anchor to the underlying notional of $1.67 per share and to the trader's directional view on GEVO stock.
GEVO strangle setup
The GEVO strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With GEVO near $1.67, the first option leg uses a $1.75 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed GEVO chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 GEVO shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $1.75 | N/A |
| Buy 1 | Put | $1.59 | N/A |
GEVO strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
GEVO strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on GEVO. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on GEVO
Strangles on GEVO are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the GEVO chain.
GEVO thesis for this strangle
The market-implied 1-standard-deviation range for GEVO extends from approximately $1.21 on the downside to $2.13 on the upside. A GEVO long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current GEVO IV rank near 24.68% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on GEVO at 96.60%. As a Basic Materials name, GEVO options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to GEVO-specific events.
GEVO strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. GEVO positions also carry Basic Materials sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move GEVO alongside the broader basket even when GEVO-specific fundamentals are unchanged. Always rebuild the position from current GEVO chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on GEVO?
- A strangle on GEVO is the strangle strategy applied to GEVO (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With GEVO stock trading near $1.67, the strikes shown on this page are snapped to the nearest listed GEVO chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are GEVO strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the GEVO strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 96.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a GEVO strangle?
- The breakeven for the GEVO strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current GEVO market-implied 1-standard-deviation expected move is approximately 27.69%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on GEVO?
- Strangles on GEVO are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the GEVO chain.
- How does current GEVO implied volatility affect this strangle?
- GEVO ATM IV is at 96.60% with IV rank near 24.68%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.